1. Home
  2. CDT vs EDBL Comparison

CDT vs EDBL Comparison

Compare CDT & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • EDBL
  • Stock Information
  • Founded
  • CDT 2019
  • EDBL 2020
  • Country
  • CDT United States
  • EDBL United States
  • Employees
  • CDT N/A
  • EDBL N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • CDT Health Care
  • EDBL Consumer Staples
  • Exchange
  • CDT Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • CDT 4.6M
  • EDBL 5.4M
  • IPO Year
  • CDT N/A
  • EDBL 2022
  • Fundamental
  • Price
  • CDT $0.77
  • EDBL $1.97
  • Analyst Decision
  • CDT
  • EDBL
  • Analyst Count
  • CDT 0
  • EDBL 0
  • Target Price
  • CDT N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • CDT 11.5M
  • EDBL 63.7K
  • Earning Date
  • CDT 11-13-2025
  • EDBL 11-12-2025
  • Dividend Yield
  • CDT N/A
  • EDBL N/A
  • EPS Growth
  • CDT N/A
  • EDBL N/A
  • EPS
  • CDT N/A
  • EDBL N/A
  • Revenue
  • CDT N/A
  • EDBL $12,320,000.00
  • Revenue This Year
  • CDT N/A
  • EDBL $29.56
  • Revenue Next Year
  • CDT N/A
  • EDBL $20.00
  • P/E Ratio
  • CDT N/A
  • EDBL N/A
  • Revenue Growth
  • CDT N/A
  • EDBL N/A
  • 52 Week Low
  • CDT $0.57
  • EDBL $1.68
  • 52 Week High
  • CDT $274.80
  • EDBL $13.50
  • Technical
  • Relative Strength Index (RSI)
  • CDT 41.63
  • EDBL 56.19
  • Support Level
  • CDT $0.65
  • EDBL $1.84
  • Resistance Level
  • CDT $0.89
  • EDBL $1.90
  • Average True Range (ATR)
  • CDT 0.07
  • EDBL 0.09
  • MACD
  • CDT 0.05
  • EDBL 0.03
  • Stochastic Oscillator
  • CDT 46.72
  • EDBL 83.33

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: